National brain tumour research funding needs to increase to £35 million a year
Join Sam and help Stop the Devastation
A brain tumour patient is calling for people to join him in saying #NoMore to brain tumours.
Dad-of-two Sam Suriakumar is sharing his story as part of our Stop the Devastation campaign to help raise awareness of brain tumours, expose the history of underfunding for research into the disease, and encourage people to donate to help find a cure.
Sam was enjoying life as a fit and healthy father to two girls, aged six and four. Married to Sindhu, a GP, and working as a part-time recruitment consultant and musician, Sam was struck down with a seizure as he travelled on the Tube. He was diagnosed with a glioma brain tumour in February 2020 but its location and diffuse nature mean it is inoperable.
He said: “My diagnosis came out of the blue and made me realise that my family is more important to me than anything. My life changed dramatically as, overnight, it meant I couldn’t work and couldn’t drive. The idea that I wouldn’t be here for Sindhu and the kids was unthinkable. We live from scan to scan and although no-one knows what lies ahead for me, I am choosing to be positive. It’s important to me that people hear my story and I hope that it will make a difference. Without more investment in research there will never be the improvements in treatment that we so badly need.”
If, like Sam, you want to Stop the Devastation, please support our #NoMore social media campaign.
It’s so easy to join in. Simply share a selfie of your “stop hand”, donate £5 and tag five friends to do the same.
To donate £5, text NOMORE to 70085. Text costs £5 plus one standard rate message and you'll be opting in to hear more about Brain Tumour Research's work and fundraising via telephone and SMS. If you'd like to give £5 but do not wish to receive marketing communications, text NOMORENOINFO to 70085.
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.